Cellyan Biotechnology Co

Cellyan Biotechnology Co EPS

The Earnings per Share (EPS) of Cellyan Biotechnology Co (HKPD) as of Nov 4, 2026 is -0.03 USD.

EPS

-0.03USD

YoY

1,182.89%

Last updated:

Earnings per Share (EPS) of Cellyan Biotechnology Co is 2026 -0.03 USD. Earnings per Share (EPS) of Cellyan Biotechnology Co was 2025 -0.00 USD. It decreases by 1,182.89% lower compared to the previous year.

The Cellyan Biotechnology Co EPS history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EPS
Date
EPS
Jan 1, 2023
0.15 USD
Jan 1, 2024
0.13 USD
Jan 1, 2025
-0.00 USD
Jan 1, 2026
-0.03 USD
The Cellyan Biotechnology Co EPS history
YEAREPSYoY
-0.03USD+1,182.89%
-0.00USD-101.93%
0.13USD-12.44%
0.15USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Cellyan Biotechnology Co Stock analysis

What does Cellyan Biotechnology Co do? Hong Kong Pharma Digital Technology Holdings Ltd is an investment holding company based in Hong Kong that operates within the Air Freight & Logistics industry. The firm is mainly engaged in the over the counter pharmaceutical business and provides two primary services to its clients. The supply chain services offer over the counter pharmaceutical cross-border e-commerce supply chain services. The procurement and distribution services provide over the counter pharmaceutical cross-border procurement and distribution services. Cellyan Biotechnology Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Cellyan Biotechnology Co stock

Earnings per Share (EPS) of Cellyan Biotechnology Co is -0.03 USD in 2026.

On Eulerpool you can find the complete historical development of Earnings per Share (EPS) Cellyan Biotechnology Co since 2006 – with annual values, charts, and detailed analysis.

Earnings per Share measures the portion of a company's profit allocated to each outstanding share. It is a key metric for assessing a company's profitability on a per-share basis.

EPS = Net Income / Shares Outstanding

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — Cellyan Biotechnology Co

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Cellyan Biotechnology Co